GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.0901 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.0901 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX15, AR, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KIT, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, XDH |
13.2098 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FDPS, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, KIT, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
12.2893 |
[BP] GO:0007187 |
None
|
ADORA1, CNR1, CNR2, DRD1, DRD2, GPER1, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
11.3539 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR2A, HTR2C |
10.8497 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, AR, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD11B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, KIT, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC |
10.281 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, GPER1, HSD11B2, HTR1B, HTR5A, PTGS2, RORC |
10.281 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AR, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, GPER1, HSD11B2, HTR1B, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC |
9.99776 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, HTR1B, HTR5A, PTGS2, RORC |
9.32367 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GPER1, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
9.22802 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GPER1, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
9.19776 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
9.10905 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, HTR1B, HTR5A, KIT, PPARA, PTGS2 |
9.04492 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AR, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD11B2, HTR1B, HTR5A, KIT, MMP2, PIK3CA, PPARA, PTGS2, RORC |
8.87458 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FDPS, FLT3, GPER1, HCAR2, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, RORC |
8.75739 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
8.5595 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B3, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
8.29571 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB |
8.28686 |
[BP] GO:0007188 |
None
|
ADORA1, CNR1, DRD1, DRD2, GPER1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
8.28205 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FDPS, FUT7, HSD17B3, HTR2B, HTR2C, MIF, PIK3CA, PPARA, PTGS1, PTGS2, XDH |
8.11068 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
8.00902 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, HTR1B, HTR5A, KIT, MMP2, PPARA, PTGS2 |
7.9802 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.95233 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.95233 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AR, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, HTR1A, HTR1B, HTR2A, HTR2B, KIT, MIF, MMP12, MMP2, MMP9, PTGS1, PTGS2, XDH |
7.82715 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.72543 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.70115 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, GPER1, HTR1B, HTR2A, KIT, PTGS2 |
7.67109 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, GPER1, HTR1B, HTR2A, KIT, PTGS2 |
7.67109 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
7.61628 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
7.54763 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
7.54763 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FDPS, FUT7, KIT, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.34674 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CNR1, DRD1, DRD2, GPER1, HCAR2, HTR2A, HTR2B, HTR2C, MIF, PIK3CB, PTGS2 |
7.34674 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CYP1B1, DRD2, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, PIK3CA, PIK3CB, PTGS2, XDH |
7.26529 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.24837 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.13672 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CSNK2A1, DRD2, ESR1, F3, FLT3, GPER1, HTR1A, HTR1B, HTR2A, HTR2B, KIT, MIF, MMP12, MMP2, MMP9, PTGS2 |
7.13181 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.13181 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
6.99015 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, AR, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
6.79697 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, AR, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
6.66307 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.60518 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2 |
6.54929 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX15, ALPL, AR, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, GPER1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, KIT, MMP1, MMP12, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC |
6.54757 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, AR, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GPER1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, KIT, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC |
6.54596 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
6.45371 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
6.45371 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
6.3459 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
6.31107 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, MIF, PTGS1, PTGS2 |
6.22733 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
6.22293 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, AR, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
6.19695 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
6.09496 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.07915 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.07568 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, GPER1, HTR2A, HTR2B, HTR2C |
6.02105 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, MIF, PTGS1, PTGS2 |
6.02105 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AR, BCL2, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, RORC |
5.9963 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GPER1, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
5.9963 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GPER1, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
5.93217 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B3 |
5.90966 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, PTGS2 |
5.84186 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, AR, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2 |
5.66416 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, AR, BCL2, DRD2, ESRRB, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
5.66416 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.66416 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.66416 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT |
5.66284 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2 |
5.5039 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3, NQO2, PTGS1, PTGS2, XDH |
5.5039 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
5.43704 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.39547 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
5.39547 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
5.34657 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, FDPS, HSD17B3, HTR1A |
5.25981 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
5.24762 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CNR1, DRD1, DRD2, GPER1, HTR1A, HTR1B, HTR2A, MIF, MMP9, PTGS2 |
5.21867 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, AR, DRD2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, PIK3CB, XDH |
5.21763 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, GPER1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
5.21763 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, AR, BCL2, DRD2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
5.20802 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX15, AR, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
5.19874 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, HTR1B, HTR2A, MMP9, PTGS2 |
5.11222 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, ESRRB, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
5.09461 |
[BP] GO:0007267 |
None
|
ADORA1, AR, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.09461 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
5.04121 |
[BP] GO:0007154 |
None
|
ADORA1, AR, BCL2, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
4.95204 |
[BP] GO:0008217 |
None
|
ADORA1, AR, CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2 |
4.94682 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGS1, PTGS2 |
4.89677 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2 |
4.88876 |
[BP] GO:0090066 |
None
|
ADORA1, ALOX15, DRD1, GPER1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.84762 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, MIF, PTGS1, PTGS2 |
4.83074 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KIT, MMP9, PTGS2 |
4.81861 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, GPER1, HSD11B2, HTR1B, PTGS2 |
4.81371 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.81353 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.81353 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
4.76166 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, DRD1, DRD2, GPER1, HCAR2, PIK3CB, PTGS2 |
4.71002 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12 |
4.69019 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR1B, HTR2A |
4.61751 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
4.60962 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.57669 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.55567 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, RORC |
4.55567 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AR, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, HTR1B, KIT, MMP2, MMP9, PIK3CA, PTGS2, RORC |
4.55122 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GPER1, HCAR2, HTR2B, KIT, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
4.53748 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D |
4.52738 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MMP9, PTGS2 |
4.49404 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AR, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, HTR1B, KIT, MMP2, PIK3CA, PTGS2, RORC |
4.48353 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
4.48353 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
4.47178 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT |
4.47178 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GPER1, HCAR2, HTR2B, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
4.41454 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, GPER1, PTGS2 |
4.41058 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.40757 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
4.39293 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, GPER1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, KIT, PIK3CA, PTGS2 |
4.36188 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, GPER1, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12 |
4.36143 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A |
4.35037 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPER1, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
4.32759 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, CNR2, GPER1, KIT, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.23171 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, DRD2, GPER1, HCAR2, HTR1A, HTR2A, HTR2C |
4.22883 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.22302 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
4.21407 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B3, HTR2A, HTR2B, HTR5A, KIT, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC |
4.1984 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2 |
4.19668 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, GPER1, PTGS2, RORC |
4.17335 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, GPER1, MIF, MMP12, PPARA, PTGS2 |
4.05763 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
4.0453 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
4.042 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, AR, BCL2, CSNK2A1, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
4.03905 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B3, KIT, PIK3CA, PPARA |
3.99158 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, GPER1, HTR1A, HTR1B, HTR2C |
3.96331 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, HTR2C, MIF |
3.96331 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
3.96331 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2, HTR1B |
3.96331 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, AR, BCL2, DRD2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.89592 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GPER1, HCAR2, HTR2B, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.88681 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, AR, BCL2, DRD2, ESR1, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.78058 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AR, BCL2, CA1, CA12, CA2, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GPBAR1, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, XDH |
3.78058 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, GPER1, HSD11B2, HTR1B, PTGS2 |
3.76952 |
[BP] GO:0016477 |
cell migration
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KIT, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB |
3.76585 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.74352 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, AR, DRD2, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, PIK3CB, XDH |
3.74352 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, AR, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
3.74057 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AOX1, AR, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR2B, HTR2C, KIT, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, XDH |
3.69494 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.69319 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, GPER1, HSD11B2, HTR1A, HTR2C, KIT, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
3.67375 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, GPER1, HTR1B, HTR1E, HTR2A, PPARA |
3.65007 |
[BP] GO:0046890 |
None
|
FABP3, FDPS, GPER1, HTR2A, HTR2B, HTR2C, PTGS2 |
3.58025 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, CNR2, DRD1, DRD2, ESR1, ESR2, GPER1, HTR1B, HTR2A, MIF, MMP12, MMP9, PTGS2, XDH |
3.57936 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, HTR1B, HTR2A, HTR2B, KIT, MMP2, PPARA, PTGS2 |
3.57494 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.56961 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, ESRRB, GPER1, HTR1B, HTR1E, HTR2A, PPARA |
3.56961 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, CNR2, DRD1, DRD2, ESR1, ESR2, GPER1, HTR1B, HTR2A, MIF, MMP12, MMP9, PTGS2, XDH |
3.56961 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, DRD2, GPER1, MMP12, PPARA |
3.52898 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AR, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B3, HTR5A, KIT, MMP9, PIK3CA, PPARA, PTGS2, RORC |
3.52392 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, FABP3, FLT3, GPER1, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
3.50973 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, HCAR2, MIF, PIK3CB |
3.50973 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.50973 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.50973 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.50973 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, HTR1D, KIT, MIF, MMP9, PTGS2 |
3.49299 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AR, BCL2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.47399 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
3.47399 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, GPER1, HTR2A, HTR2B, HTR2C |
3.47024 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.46145 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGS1, PTGS2 |
3.46145 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, KIT, MIF, MMP9, PTGS2 |
3.45645 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.45198 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, AR, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
3.44349 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
3.43351 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12 |
3.43259 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP3A4, FDPS, HSD17B3, MIF, PTGS1, PTGS2 |
3.4295 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.41971 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.41971 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.41971 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, AR, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, ESR2, GPER1, MIF, MMP12, MMP9, PPARA, PTGS2, XDH |
3.41767 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.39407 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, PIK3CA |
3.39182 |
[BP] GO:0048870 |
cell motility
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KIT, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB |
3.38198 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.37569 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
3.37569 |
[BP] GO:0003012 |
None
|
ADORA1, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.3458 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CNR1, DRD2, GPER1, HCAR2, HTR2B, HTR2C, MIF, MMP12 |
3.34167 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.3243 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31761 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.31693 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.297 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, GPER1, HTR5A, PTGS2 |
3.29071 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B, KIT |
3.28001 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, ESR1, ESRRA, GPER1, HCAR2, KIT, MIF, MMP12, MMP2, PIK3CA, PIK3CB |
3.27942 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AR, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, RORC, XDH |
3.25579 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, AR, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
3.24558 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, FABP3, FLT3, GPER1, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
3.22393 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, GPER1, HTR1B, MMP2, MMP9, PTGS2 |
3.22336 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AR, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HCAR2, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, RORC, XDH |
3.21841 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, KIT, MIF, MMP9, PTGS2 |
3.21769 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.2173 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, GPER1, HTR2A, HTR2B, HTR2C, MIF |
3.2173 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.21147 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.21147 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.21147 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, GPER1, MIF, PPARA |
3.20803 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
3.1692 |
[BP] GO:0032787 |
None
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
3.16031 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, ESR1, HTR7, KIT, PPARA, RORC |
3.1567 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B, KIT |
3.15578 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.1225 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A |
3.1225 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.1225 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12 |
3.11806 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, MIF, PTGS1, PTGS2 |
3.11537 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.10559 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.09268 |
[BP] GO:0006952 |
defense response
|
ADORA1, ADORA3, ALOX15, BCL2, CNR2, DRD1, GPER1, HTR1A, HTR2C, KIT, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.08105 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, GPER1, PPARA, PTGS2 |
3.07193 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
DRD2, F3, GPER1, KIT, PIK3CA, PIK3CB, XDH |
3.05211 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, AR, BCL2, DRD1, DRD2, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.03385 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, HTR1B, MMP2, MMP9 |
3.03385 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.03385 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.01855 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
3.0093 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
3.0093 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
3.0093 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.0093 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.00545 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, KIT, PIK3CA, PIK3CB |
2.95533 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.94668 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, CNR1, CNR2, CYP19A1, DRD2, GPER1, MIF, MMP12 |
2.94131 |
[BP] GO:0040011 |
locomotion
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KIT, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB |
2.93452 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, PPARA |
2.92762 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.92762 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, GPER1, KIT, MIF, MMP9, PTGS2 |
2.89832 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
2.88627 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.8501 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, PIK3CB, XDH |
2.84993 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2 |
2.84983 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.81856 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.81856 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B3, KIT, MMP2, MMP9, PTGS2 |
2.80261 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12 |
2.79186 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, AR, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GPER1, HCAR2, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
2.77984 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.77544 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, ESR1, FABP4, GPER1, MMP12, MMP2, PPARA, PTGS2 |
2.77143 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.75833 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
2.75274 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.7467 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.7467 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AR, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, F3, GPER1, HCAR2, HTR2A, HTR2B, KIT, MIF, MMP12, MMP9, PTGS2 |
2.74656 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, FDPS, HSD17B3 |
2.73257 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.73257 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.68869 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C |
2.65976 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AR, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, HTR1B, KIT, MIF, MMP2, MMP9, PIK3CA, PTGS2, RORC |
2.65976 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CNR1, DRD2, GPER1, HCAR2, HTR2B, HTR2C, MIF, MMP12, PTGS2 |
2.65386 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.59328 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.59264 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, BCL2, CA2, CYP19A1, DRD1, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12, PTGS2 |
2.59199 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, GPER1, HTR1A, PTGS2 |
2.59025 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.58979 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58979 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.58979 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, KIT, MIF, MMP1, MMP9, PIK3CA, PIK3CB |
2.58979 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, PTGS2 |
2.5848 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12 |
2.54901 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS |
2.54809 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.5448 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, HCAR2, HTR2B, PIK3CA, PPARA |
2.52105 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.51579 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, KIT, MIF, PIK3CB |
2.51321 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.50412 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.49578 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AR, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F3, FLT3, GPER1, HTR2A, HTR2B, HTR2C, HTR6, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.49213 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, HTR1A |
2.48518 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ALOX15, AR, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GPER1, HCAR2, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RORC, XDH |
2.48163 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AR, BCL2, CA2, CNR1, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, GPER1, HCAR2, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP12, MMP9, PIK3CA, PTGS2, XDH |
2.47922 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.46589 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.46304 |
[BP] GO:0050890 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR2A, KIT, PTGS2 |
2.44409 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.43562 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, GPER1, HTR2A, HTR2B, HTR2C, MIF |
2.42655 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, AOX1, AR, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR2B, HTR2C, KIT, MIF, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, XDH |
2.42245 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, GPER1, PPARA |
2.42126 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.41826 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.41672 |
[BP] GO:0030814 |
None
|
DRD1, DRD2, GPER1, HTR1B, HTR1E |
2.40705 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, GPER1, HCAR2, MMP9, PIK3CB, PTGS2, XDH |
2.4035 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AR, BCL2, CNR1, CNR2, CSNK2A1, DRD2, ESR1, ESR2, ESRRA, FABP4, GPER1, HCAR2, HTR1B, HTR1E, HTR2B, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, RORC, XDH |
2.38989 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.38989 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.38989 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.37972 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, GPER1, HCAR2, MMP9, PIK3CB, PTGS2, XDH |
2.37409 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.36943 |
[BP] GO:0090407 |
organophosphate biosynthetic process
|
ACHE, ALOX15, CSNK2A1, FDPS, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2 |
2.3692 |
[BP] GO:0045598 |
None
|
GPER1, HTR2A, HTR2C, PTGS2, RORC |
2.35014 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.35014 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.35014 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35014 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C |
2.35014 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FDPS, HTR2B, HTR2C, KIT, PIK3CA, PIK3CB, PTGS2, XDH |
2.35014 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.35014 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.35014 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.35014 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35014 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.35014 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, CYP1B1, DRD1, ESR1, GPER1, MMP2, MMP9, PIK3CA, PTGS2, RORC |
2.33887 |
[BP] GO:0060402 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.31213 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.31213 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.30512 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.30512 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30512 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AR, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, KIT, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
2.29906 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS |
2.29363 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.29363 |
[BP] GO:0006940 |
None
|
ADORA1, GPER1, KIT, PTGS2 |
2.29363 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, DRD2, FLT3, HTR2A, HTR2B, KIT, MIF, PIK3CA, PIK3CB |
2.27018 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.26602 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, BCL2, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12, PTGS2 |
2.26599 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, GPER1, MMP9, PTGS2, XDH |
2.24823 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, DRD2, GPER1, HCAR2, HTR2A, HTR2C, KIT, PTGS2 |
2.24271 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, HTR2A, PPARA |
2.22363 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KIT, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2 |
2.22335 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.21525 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.21525 |
[BP] GO:0006693 |
None
|
MIF, PTGS1, PTGS2 |
2.21525 |
[BP] GO:0006692 |
None
|
MIF, PTGS1, PTGS2 |
2.21525 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FDPS, KIT, PIK3CA, PIK3CB |
2.21052 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, BCL2, CYP1A1, ESR1, FLT3, HTR1A, KIT, MIF, PIK3CB |
2.1904 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AR, BCL2, DRD2, ESR1, ESR2, F3, FLT3, GPER1, HTR2A, HTR2B, KIT, MIF, MMP9, PIK3CA, PIK3CB, XDH |
2.16575 |
[BP] GO:1900543 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.16575 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.16575 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.16575 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.16575 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.16575 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.16575 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.16575 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.16437 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, F3, GPER1, HCAR2, MMP9, PIK3CB, PTGS2, XDH |
2.16437 |
[BP] GO:0045980 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.14732 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.13317 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.12613 |
[BP] GO:0050708 |
None
|
ACHE, CNR1, DRD2, GPER1, HCAR2, HTR2B, MIF, MMP12 |
2.12002 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, BCL2, CSNK2A1, HTR2B, KIT, MIF, MMP9, PIK3CA, PPARA, PTGS2 |
2.1123 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, GPER1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.11028 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, FLT3, HSD11B2, PTGS2 |
2.11028 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, DRD2, FLT3, HTR2A, HTR2B, KIT, MIF, PIK3CA, PIK3CB |
2.09356 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.08679 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, AR, BCL2, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GPER1, HTR2A, HTR2B, HTR2C, KIT, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.07206 |
[BP] GO:0030799 |
None
|
DRD1, DRD2, GPER1, HTR1B, HTR1E |
2.071 |
[BP] GO:0060401 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.06758 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AR, DRD1, ESR1, FLT3, GPER1, HTR1B, KIT, MMP2, PTGS2 |
2.06231 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.04764 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1 |
2.02697 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1B |
2.0243 |
[BP] GO:0007568 |
aging
|
BCL2, CNR1, CYP1A1, HTR2A, MIF, PTGS2 |
2.0243 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, HTR1B |
2.0243 |
[BP] GO:0045777 |
None
|
ADORA1, CNR1, HSD11B2 |
2.0243 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.0243 |
[BP] GO:0033029 |
regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.0243 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.0243 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.0243 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.0243 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.0243 |
[BP] GO:0014831 |
None
|
HTR1D, HTR2B |
2.0243 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.0243 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.0243 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.0243 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.02352 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.02352 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX15, CYP1A1, MIF, PTGS1, PTGS2 |
2.01091 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, ESR1, F3, FABP4, GPER1, MIF, MMP12, MMP2, PPARA, PTGS2, XDH |
2.01091 |
[BP] GO:0045833 |
None
|
ADORA1, CNR1, GPER1, HCAR2 |
2.00632 |
[BP] GO:1901570 |
None
|
ALOX15, MIF, PTGS1, PTGS2 |
2.00632 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, CA4, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GPER1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.24623 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GPBAR1, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.18066 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, AR, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, MMP2, PIK3CA, PIK3CB |
5.0093 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, AR, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GPBAR1, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.48353 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, FLT3, GPER1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.28205 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GPER1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, PTGS2 |
3.94433 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, GPER1, HSD11B1, HSD11B2, HSD17B3, PTGS1, PTGS2 |
3.37839 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, FLT3, GPER1, HSD11B1, HSD11B2, HSD17B3, PTGS1, PTGS2 |
2.49691 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.0901 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.0901 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.9018 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.9018 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
14.6671 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
14.4921 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
13.1935 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, PPARA, RORC |
12.7315 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
12.7315 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, RORC, XDH |
12.5673 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, PPARA, RORC |
11.4185 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
11.4185 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, PPARA, RORC |
11.125 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD11B2, HSD17B1, RORC, SHBG |
10.8512 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, AR, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FDPS, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2, RORC, XDH |
10.5881 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT, PPARA, RORC |
10.4449 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.4449 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALPL, AOX1, AR, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, XDH |
10.3313 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.33319 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.33319 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
8.008 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.78421 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT |
7.78421 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GPBAR1, GPER1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, KIT |
7.78421 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4 |
6.88431 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, RORC |
6.86383 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3, NQO2, PTGS1, PTGS2, XDH |
6.68302 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.50914 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GPER1, HSD11B2, HSD17B1, PPARA, RORC, SHBG |
6.29766 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, XDH |
5.84186 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.66416 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
5.45798 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.44134 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, PTGS1, PTGS2 |
5.39547 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, PTGS1, PTGS2 |
5.18066 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, PTGS1, PTGS2 |
4.83074 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.22302 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.12155 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B3, XDH |
4.11079 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, NQO2, SHBG |
4.09446 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4 |
3.84021 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, AR, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, GPER1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MMP12, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, SHBG, XDH |
3.70293 |
[MF] GO:0008144 |
drug binding
|
ACHE, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, KIT, NQO2, PIK3CA, PIK3CB, PPARA |
3.6576 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, AR, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FDPS, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2, RORC, XDH |
3.59233 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.56206 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
3.56206 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
3.46145 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.43796 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.37569 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, F3, FDPS, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, KIT, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PTGS1, PTGS2, XDH |
3.29942 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP3A4 |
3.23379 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.0093 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.0093 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
3.0093 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
3.0093 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.58979 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.58979 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.58979 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
2.36521 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.35014 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.35014 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.35014 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.35014 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, AR, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MMP12, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, RORC, XDH |
2.33887 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.16575 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0243 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.0243 |